Tokai Pharmaceuticals Company Profile (NASDAQ:TKAI)

About Tokai Pharmaceuticals

Tokai Pharmaceuticals logoTokai Pharmaceuticals, Inc. is a United States-based biopharmaceutical company. The Company focuses on developing and commercializing therapies for prostate cancer and other hormonally-driven diseases. The Company's lead drug candidate, galeterone, is an oral small molecule that utilizes the mechanistic pathways of second-generation androgen signaling inhibitors, while also introducing a mechanism called androgen receptor degradation, including impairing the function of androgen receptors. The Company is developing galeterone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC). Androgen Receptor Modulation Optimized for Response (ARMOR) is its clinical development program for the evaluation of galeterone in patients with prostate cancer. Its drug discovery platform, androgen receptor degradation agents (ARDA), enables the Company to identify and develop compounds with potent androgen receptor degradation activity.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TKAI
  • CUSIP:
Key Metrics:
  • Previous Close: $0.89
  • 50 Day Moving Average: $0.976
  • 200 Day Moving Average: $1.144
  • 52-Week Range: $22,641,000.00 - $0.73
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.14
  • P/E Growth: 0.010
  • Market Cap: $20.13M
  • Outstanding Shares: 22,641,000
  • Beta: 1
Profitability:
  • Return on Equity: -99.29%
  • Return on Assets: -86.48%
Debt:
  • Current Ratio: 5.73%
  • Quick Ratio: 5.73%
Additional Links:
Companies Related to Tokai Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Tokai Pharmaceuticals (NASDAQ:TKAI) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings
Consensus Rating:Hold (Score: 1.83)
Consensus Price Target: $9.72 (992.99% upside)

Analysts' Ratings History for Tokai Pharmaceuticals (NASDAQ:TKAI)
Show:
DateFirmActionRatingPrice TargetDetails
8/24/2016BMO Capital MarketsReiterated RatingMarket Perform$1.70 -> $1.15View Rating Details
8/10/2016William BlairReiterated RatingNeutralView Rating Details
7/28/2016Bank of America CorpDowngradeNeutral -> UnderperformView Rating Details
7/26/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
7/26/2016Janney Montgomery ScottDowngradeBuy -> NeutralView Rating Details
7/26/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformView Rating Details
2/11/2016Oppenheimer Holdings, Inc.Reiterated RatingOutperformView Rating Details
(Data available from 2/19/2015 forward)

Earnings

Earnings History for Tokai Pharmaceuticals (NASDAQ:TKAI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/12/2016        
5/10/2016Q1($0.50)($0.51)ViewN/AView Earnings Details
3/10/2016Q4($0.47)($0.49)ViewN/AView Earnings Details
11/10/2015Q3($0.53)($0.53)ViewN/AView Earnings Details
8/12/2015Q215($0.50)($0.40)ViewN/AView Earnings Details
5/12/2015Q115($0.31)($0.59)ViewN/AView Earnings Details
3/12/2015($0.40)($0.28)ViewN/AView Earnings Details
11/10/2014($0.42)($2.71)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tokai Pharmaceuticals (NASDAQ:TKAI)
Current Year EPS Consensus Estimate: $-1.900 EPS
Next Year EPS Consensus Estimate: $-0.780 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.56)($0.56)($0.56)
Q2 20161($0.63)($0.63)($0.63)
Q3 20161($0.68)($0.68)($0.68)
Q4 20161($0.73)($0.73)($0.73)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tokai Pharmaceuticals (NASDAQ:TKAI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tokai Pharmaceuticals (NASDAQ:TKAI)
Insider Ownership Percentage: 39.90%
Institutional Ownership Percentage: 12.31%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/15/2016Stephen Jr. BuckleyDirectorBuy8,000$5.74$45,920.00View SEC Filing  
11/11/2015Stephen Jr. BuckleyDirectorBuy3,000$11.25$33,750.00View SEC Filing  
9/21/2015John S. McbrideCOOSell13,500$14.01$189,135.00View SEC Filing  
9/8/2015Lee KalowskiCFOSell4,668$13.13$61,290.84View SEC Filing  
9/2/2015Lee KalowskiCFOSell2,158$12.96$27,967.68View SEC Filing  
7/15/2015Bioventures Ltd NovartisMajor ShareholderSell3,566$14.26$50,851.16View SEC Filing  
7/14/2015Bioventures Ltd NovartisMajor ShareholderSell27,861$14.41$401,477.01View SEC Filing  
7/13/2015Bioventures Ltd NovartisMajor ShareholderSell20,611$14.20$292,676.20View SEC Filing  
6/29/2015Jodie Pope MorrisonCEOSell16,000$13.77$220,320.00View SEC Filing  
6/24/2015John S McbrideCOOSell9,000$14.01$126,090.00View SEC Filing  
6/23/2015John S McbrideCOOSell6,700$14.00$93,800.00View SEC Filing  
6/22/2015John S McbrideCOOSell2,000$14.02$28,040.00View SEC Filing  
6/16/2015Bioventures Ltd NovartisMajor ShareholderSell1,120$14.27$15,982.40View SEC Filing  
6/11/2015Bioventures Ltd NovartisMajor ShareholderSell27,875$14.20$395,825.00View SEC Filing  
4/16/2015Lee KalowskiCFOSell4,567$13.00$59,371.00View SEC Filing  
4/2/2015Lee KalowskiCFOSell2,258$11.45$25,854.10View SEC Filing  
3/19/2015Bioventures Ltd NovartisMajor ShareholderSell49,141$14.50$712,544.50View SEC Filing  
9/22/2014Apple Tree Partners Ii - AnnexDirectorBuy237,500$15.00$3,562,500.00View SEC Filing  
9/22/2014Bioventures Ltd NovartisMajor ShareholderBuy325,000$15.00$4,875,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tokai Pharmaceuticals (NASDAQ:TKAI)
DateHeadline
News IconStock On Watchlist: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Price Target Watch - Rockville Register (NASDAQ:TKAI)
rockvilleregister.com - February 17 at 7:03 PM
News IconConsensus Take: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Earnings & Ratings Watch - Aiken Advocate (NASDAQ:TKAI)
aikenadvocate.com - February 13 at 8:47 PM
News IconTechnical Watch on These Shares: Tokai Pharmaceuticals Inc. (TKAI) - Sherwood Daily (NASDAQ:TKAI)
sherwooddaily.com - February 1 at 6:54 AM
News IconCalling all Bargain Hunters: Stock Update on Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - February 1 at 6:54 AM
News IconTokai Pharmaceuticals Inc TKAI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:TKAI)
www.bioportfolio.com - January 31 at 3:56 AM
News IconMarket Review: Indicator Watch for Tokai Pharmaceuticals Inc. (TKAI) - Sherwood Daily (NASDAQ:TKAI)
sherwooddaily.com - January 23 at 11:50 PM
News IconStock Perspective: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Company Earnings Watch - Aiken Advocate (NASDAQ:TKAI)
aikenadvocate.com - January 23 at 11:50 PM
News IconEquity Insight: Indicator Review for Tokai Pharmaceuticals Inc. (TKAI) - Sherwood Daily (NASDAQ:TKAI)
sherwooddaily.com - January 18 at 1:05 AM
News IconBoom or Bust? Is there any value in Tokai Pharmaceuticals, Inc ... - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - January 18 at 1:05 AM
News IconHoning in on Shares of Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI ... - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - January 18 at 1:05 AM
News IconCan This Stock Price Climb The Ladder: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - January 13 at 12:34 AM
News IconWill The Needle Move For Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:TKAI)
wsbeacon.com - January 13 at 12:34 AM
News IconMarching to the Beat of Their Own Drum, Update on Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - January 12 at 3:16 AM
News IconIs the Needle Ready to Move on Tokai Pharmaceuticals, Inc ... - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - January 11 at 6:26 AM
News IconPlacing This Stock in the Hotbed: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - January 11 at 6:26 AM
News IconAstute Investors Are Taking a Look at Tokai Pharmaceuticals, Inc ... - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - January 6 at 6:09 AM
istreetwire.com logo3 Trending Stocks: Tokai Pharmaceuticals, Inc. (TKAI), Lockheed ... - iStreetWire (NASDAQ:TKAI)
istreetwire.com - December 28 at 8:49 AM
News IconCan This Stock Grab Upward Traction: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - December 28 at 8:49 AM
News IconAnalysts At Credit Suisse Reiterated Portola Pharmaceuticals (NASDAQ:PTLA) As Outperform (NASDAQ:TKAI)
baddgoddess.com - December 27 at 7:53 PM
News IconStock to Track: Portola Pharmaceuticals Inc (NASDAQ:PTLA) (NASDAQ:TKAI)
www.xboxonezone.com - December 27 at 7:53 PM
bizjournals.com logoResearch Reports Initiation on Biotech Stocks -- Progenics Pharma, Tokai Pharma, Ophthotech, and Lexicon Pharma (NASDAQ:TKAI)
www.bizjournals.com - December 27 at 8:47 AM
News IconReviewing Individual Broker Targets Of Time Warner Inc. (NYSE:TWX) (NASDAQ:TKAI)
myhealthbowl.com - December 25 at 7:25 PM
News IconKerala minister MM Mani to face trial in Anchery Baby murder (NASDAQ:TKAI)
baddgoddess.com - December 25 at 8:38 AM
bizjournals.com logo​Boston-based Tokai throws in the towel, sells public shell to Israeli biotech (NASDAQ:TKAI)
www.bizjournals.com - December 23 at 9:15 PM
News IconOtic uptick for Tokai; reverse merger to support ENT pipeline (NASDAQ:TKAI)
www.bioworld.com - December 23 at 2:00 AM
4-traders.com logoNetworkNewsBreaks – Tokai Pharmaceuticals (NASDAQ: TKAI) Trades Higher on Share Purchase Agreement with Otic Pharma (NASDAQ:TKAI)
www.4-traders.com - December 23 at 2:00 AM
streetinsider.com logoOtic Pharma to Become Majority Owner of Tokai Pharma (TKAI) (NASDAQ:TKAI)
www.streetinsider.com - December 23 at 2:00 AM
finance.yahoo.com logo8:01 am Tokai Pharma and privately-held Otic pharma to merge; name will change to OticPharma; TKAI shareholders will own 40% of combined company (NASDAQ:TKAI)
finance.yahoo.com - December 23 at 2:00 AM
publicnow.com logoTokai Pharmaceuticals and Otic Pharma Enter into Share Purchase Agreement (NASDAQ:TKAI)
www.publicnow.com - December 23 at 2:00 AM
biz.yahoo.com logoTOKAI PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity (NASDAQ:TKAI)
biz.yahoo.com - December 23 at 2:00 AM
News IconBargain Hunters Should Take a Look at Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Prospect Journal (NASDAQ:TKAI)
prospectjournal.com - December 21 at 2:33 AM
News IconDeadline on Dec. 13th Upcoming in Lawsuit for Investors in Tokai Pharmaceuticals Inc (NASDAQ:TKAI) - Digital Journal (NASDAQ:TKAI)
www.digitaljournal.com - December 12 at 8:29 PM
sbwire.com logoDeadline on Dec. 13th Upcoming in Lawsuit for Investors in Tokai Pharmaceuticals Inc (NASDAQ:TKAI) (NASDAQ:TKAI)
www.sbwire.com - December 12 at 3:28 PM
rttnews.com logoFrom Hype To Flop: 10 Biotech Stocks That Let Down Investors In 2016 (NASDAQ:TKAI)
www.rttnews.com - December 7 at 8:07 AM
News IconTokai Pharmaceuticals, Inc. (TKAI) Under Analyst Spotlight - UK ... - UK Market News (NASDAQ:TKAI)
www.ukmarketnews.co.uk - November 25 at 8:17 AM
News IconTokai Pharmaceuticals, Inc. (TKAI) Broker Views On Wall Street ... - NewsDen (NASDAQ:TKAI)
newsden.net - November 24 at 7:48 PM
News IconTrend Strength Monitor on Shares of Tokai Pharmaceuticals Inc. (TKAI) - MicroCap Wired (NASDAQ:TKAI)
www.microcapwired.com - November 24 at 7:48 PM
News IconChecking Share Average and RSI Levels on Tokai Pharmaceuticals Inc. (TKAI) - MicroCap Wired (NASDAQ:TKAI)
www.microcapwired.com - November 22 at 8:02 PM
News IconWonder Stock Alert: Investors Curious About Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Duncan Research (NASDAQ:TKAI)
www.duncanindependent.com - November 22 at 8:02 PM
News IconWhat are Research Firms Saying About Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI)? - CSZ News (NASDAQ:TKAI)
cincysportszone.com - November 21 at 8:24 PM
News IconStock Watch: Indicators in View for Tokai Pharmaceuticals Inc. (TKAI) - MicroCap Wired (NASDAQ:TKAI)
www.microcapwired.com - November 21 at 8:24 PM
News IconMA Levels in Review for Tokai Pharmaceuticals Inc. (TKAI) - MicroCap Wired (NASDAQ:TKAI)
www.microcapwired.com - November 20 at 11:55 AM
News IconTokai Pharmaceuticals, Inc. TKAI Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:TKAI)
www.bioportfolio.com - November 18 at 11:20 AM
News IconAPPROACHING DEADLINE: WeissLaw LLP Announces a Class Action Lawsuit Has Been Filed On Behalf of Shareholders Tokai Pharmaceut... (NASDAQ:TKAI)
ih.advfn.com - November 17 at 12:21 PM
prnewswire.com logoAPPROACHING DEADLINE: WeissLaw LLP Announces a Class Action Lawsuit Has Been Filed On Behalf of ... - PR Newswire (press release) (NASDAQ:TKAI)
www.prnewswire.com - November 16 at 8:09 PM
News IconInside Track: Trading Focus on Shares of Tokai Pharmaceuticals Inc. (TKAI) - MicroCap Wired (NASDAQ:TKAI)
www.microcapwired.com - November 16 at 8:09 PM
finance.yahoo.com logoAPPROACHING DEADLINE: WeissLaw LLP Announces a Class Action Lawsuit Has Been Filed On Behalf of Shareholders Tokai Pharmaceuticals, Inc. (TKAI) (NASDAQ:TKAI)
finance.yahoo.com - November 16 at 8:09 PM
finance.yahoo.com logoTOKAI PHARMACEUTICALS INC Financials (NASDAQ:TKAI)
finance.yahoo.com - November 15 at 8:42 PM
News IconSell-side is Weighing in on Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Earnings & Targets - CSZ News (NASDAQ:TKAI)
cincysportszone.com - November 14 at 12:07 PM
4-traders.com logoTokai Pharmaceuticals : Biotech Stocks Under Scanner -- Anavex Life Sciences, Eleven Biotherapeutics, Achillion Pharma, and Tokai Pharma (NASDAQ:TKAI)
www.4-traders.com - November 11 at 10:54 AM

Social

What is Tokai Pharmaceuticals' stock symbol?

Tokai Pharmaceuticals trades on the NASDAQ under the ticker symbol "TKAI."

Where is Tokai Pharmaceuticals' stock going? Where will Tokai Pharmaceuticals' stock price be in 2017?

6 equities research analysts have issued 1 year price objectives for Tokai Pharmaceuticals' shares. Their predictions range from $1.15 to $16.00. On average, they expect Tokai Pharmaceuticals' share price to reach $9.72 in the next year.

When will Tokai Pharmaceuticals announce their earnings?

Tokai Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Friday, August, 12th 2016.

Who owns Tokai Pharmaceuticals stock?

Tokai Pharmaceuticals' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (1.59%) and State Street Corp (0.61%). Company insiders that own Tokai Pharmaceuticals stock include Bioventures Ltd Novartis, Jodie Pope Morrison, John S Mcbride, Lee Kalowski and Stephen Jr Buckley.

Who bought Tokai Pharmaceuticals stock? Who is buying Tokai Pharmaceuticals stock?

Tokai Pharmaceuticals' stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and State Street Corp.

How do I buy Tokai Pharmaceuticals stock?

Shares of Tokai Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Tokai Pharmaceuticals stock cost?

One share of Tokai Pharmaceuticals stock can currently be purchased for approximately $0.89.

Tokai Pharmaceuticals (NASDAQ:TKAI) Chart for Sunday, February, 19, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Tokai Pharmaceuticals (NASDAQ:TKAI)

Earnings History Chart

Earnings by Quarter for Tokai Pharmaceuticals (NASDAQ:TKAI)

Dividend History Chart

Dividend Payments by Quarter for Tokai Pharmaceuticals (NASDAQ:TKAI)

Last Updated on 2/19/2017 by MarketBeat.com Staff